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Abstract
Ror proteins are a conserved family of tyrosine kinase receptors that function in developmental 
processes, including skeletal and neuronal development, cell movement, and cell polarity. While 
Ror (receptor tyrosine kinase-like orphan receptor) proteins were originally named because the 
associated ligand and signaling pathway were unknown, recent studies in multiple species now 
establish that Ror proteins are Wnt receptors. Depending on the cellular context, Ror proteins can 
either activate or repress transcription of Wnt target genes and can modulate Wnt signaling by 
sequestering Wnt ligands. New evidence implicates Ror proteins in planar cell polarity (PCP), an 
alternative Wnt pathway. Here, we review the progress made in understanding these mysterious 
proteins and in particular we focus on their function as Wnt receptors.
Introduction
Receptor tyrosine kinases (RTKs) play crucial roles in many cellular processes including 
differentiation, proliferation, migration, angiogenesis and survival. Therefore, it is not 
surprising that dysfunctional RTKs cause severe developmental defects and diseases such as 
cancer. Ror proteins are no exception and disruptions of human Ror proteins are associated 
with skeletal deformities and with leukemia. RTKs normally enable communication between 
a cell and its environment by binding to an extracellular ligand and initiating an intracellular 
signaling cascade. For a long time, the Ror family of RTKs was one of the few types of 
RTK whose ligand and signaling pathway remained elusive, giving rise to their ‘orphan’ 
nomenclature; however, recent work has greatly advanced our understanding of Ror 
function. In particular, Ror proteins have emerged as central regulators of Wnt signaling, an 
important developmental signaling pathway.
Ror proteins are type I transmembrane receptor tyrosine kinases (Figure 1). Like other 
RTKs, they are predominantly located in the plasma membrane [1]. The extracellular region 
of vertebrate Ror proteins contains an immunoglobulin (Ig) domain, a cysteine-rich domain 
(CRD), also called a Frizzled domain, and a Kringle (Kr) domain. Intracellularly, Ror 
proteins possess a tyrosine kinase (TK) domain, and a proline-rich domain straddled by two 
serine-threonine-rich (S/T1 and S/T2) domains [2].
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Vertebrates have two ROR family members encoded by ROR1 and ROR2 (formerly known 
as NTRKR1 and NTRKR2, respectively), first identified in a human neuroblastoma cell line 
by a PCR-based search for tyrosine kinases similar to Trk neurotrophic receptors [2]. Splice 
variants of ROR1 encoding truncated proteins lacking either the extracellular domains [3] or 
the transmembrane and intracellular domains (Genbank locus NM_001083592) have been 
described. Since the former, called truncated ROR1 (t-ROR1), might be artefactual [4] and 
the latter has not been analyzed in detail, in this review we will consider only full-length 
ROR proteins. Despite their lack of several amino acids highly conserved in protein tyrosine 
kinases, ROR1 and ROR2 each have kinase activity in vitro [2, 5]. ROR orthologs have been 
identified in fruit flies (Drosophila melanogaster; dROR) [6], roundworms (Caenorhabditis 
elegans; cam-1) [7, 8], sea slugs (Aplysia californica; Apror) [9], zebrafish (Danio rerio; 
Ror2 and Ror2) [10], chickens (Gallus gallus; cRor1 and cRor2) [11, 12], frogs (Xenopus 
laevis; XRor1 and XRor2) [13] and mice (Mus musculus; mRor1 and mRor2) [5]. 
Drosophila Dnrk [14] has been excluded here as it is now thought of as a MuSK ortholog 
[15] (see Box 1). While the CRD, Kringle and TK domains are characteristic of all ROR 
proteins, the architecture of the other domains varies between species (Figure 1).
The extracellular CRD of Ror is similar to the Wnt-binding domain found in Frizzled 
receptors [16-20], suggesting that Ror proteins also bind to Wnt ligands. This was later 
shown (see below). Wnt proteins are a family of secreted glycoproteins that play crucial 
roles in development and disease (reviewed by [21]). In the classic model of Wnt signaling, 
a Wnt ligand binds to a Frizzled (Fzd) receptor and to the Lrp5/6 co-receptor. This 
interaction results in the stabilization of cytoplasmic β-catenin, allowing it to accumulate, 
translocate to the nucleus, and act as a transcriptional co-activator with TCF, a DNA-binding 
protein. Other mechanisms of Wnt signaling include Wnt–calcium signaling, Wnt–JNK 
signaling and the planar cell polarity (PCP) pathway (reviewed by [22]). The degree to 
which these pathways overlap is presently unclear.
Several studies report diverse, and sometimes conflicting, interactions of Ror with Wnt 
signaling. It is likely that the discrepancies reflect the diversity of systems tested, with Ror 
proteins in fact having multiple functions depending on the cellular context (the coexistence 
of other Wnt pathway components operating in a given cell). In this review, we have 
clustered compatible observations into a handful of signaling mechanisms, discussed in 
detail below, following a brief account of Ror function during development. We conclude 
with a description of other Ror interactions not yet associated with Wnt signaling.
Ror function during development
In humans, Ror protein functions are known primarily in skeletal development. hROR2 
mutations cause well-characterized skeletal defects: dominant brachydactyly type B (BDB), 
a condition of shortened or missing digits [23, 24], and recessive Robinow syndrome (RRS), 
a form of short-limbed dwarfism [25, 26]. Ror2 polymorphisms are also associated with 
variations in human bone length and mineral density [27]. In mouse and chick, Ror genes 
play a partially redundant role in skeletal development and are also required for 
development of the cardiac and respiratory systems [1, 4, 5, 28-32]. Notably, the skeletal 
defects of mRor2 mutant mice, dwarfism, shortened limbs and facial abnormalities, 
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resemble the deformities of the human disease RRS. While mutations in hROR1 have not 
been linked to any human disease, hROR1 is overexpressed in chronic lymphocytic 
leukemia (CLL) and confers a survival advantage to these cells in vitro [33, 34]. Consistent 
with there being role for hROR1 in cancer, ROR1 was identified as a potent survival kinase 
in HeLa cervical carcinoma cells [35]. The signaling events downstream of Ror receptors, 
which are still largely unknown, will need to be deciphered in order to treat Ror-based 
diseases and malignancies. Table 1 presents a summary of the biological functions and 
expression patterns of Ror proteins.
Although Ror proteins are strongly expressed in the developing nervous systems of many 
species (Table 1), the role of Ror proteins in neuronal development remains unclear. The 
mutant phenotype of dROR, which is expressed exclusively in the developing nervous 
system of Drosophila [6] has not been described. In mice, although the largely non-
overlapping expression patterns of mROR1 and mROR2 in the developing nervous system 
makes redundancy unlikely, mROR2 knockout mice do not display obvious neurological 
defects [4, 5]; however, it is possible that a subtle phenotype is masked by the early lethality 
of these mice.
Despite the apparent lack of a vertebrate neuronal phenotype, strong neuronal expression 
and structural similarity to MuSK (muscle-specific kinase) protein, which is an RTK 
required for synapse formation [36], suggest that Ror proteins are involved in neuronal 
development. Evidence supporting this comes from C. elegans, where CAM-1 regulates 
neuronal migration, axon outgrowth and axon guidance [8, 37-39]. CAM-1 also regulates 
the localization of acetylcholine receptors at the neuromuscular synapse [40], a function 
performed by the MuSK receptor in mammals [36]. Interestingly, although CAM-1's closest 
homolog is Ror, CAM-1 turns up as the closest homolog for both Ror and MuSK in C. 
elegans (see Box 1), raising the possibility that CAM-1 fulfills the roles of both Ror and 
MuSK. While it is unknown whether Ror proteins perform neuronal functions in species that 
have a distinct MuSK protein, Ror proteins display a localization pattern in cultured 
mammalian neurons consistent with functions in neurite extension and the organization of 
neuronal subdomains [9, 41-43].
Functions of Ror as a Wnt receptor
ROR proteins sequester Wnt ligands
A series of studies led to the discovery that CAM-1, the C. elegans Ror protein, inhibits the 
function of a C. elegans Wnt ligand, EGL-20 [8, 39, 44]. It was first shown that cam-1 
mutations cause defects in the migration of several neurons along the anterior–posterior axis 
[8]. This migration phenotype was later determined to be reciprocal to the phenotype caused 
by loss of the Wnt ligand egl-20 [39]. Further investigation revealed that cam-1 
overexpression mimics the egl-20 mutant phenotype and that egl-20 overexpression mimics 
the cam-1 mutant phenotype. Thus, cam-1 and Wnt/egl-20 appeared to have an antagonistic 
relationship. Experiments using engineered cam-1 deletions showed that the membrane-
anchored CAM-1 CRD was sufficient to rescue cell migration in cam-1 mutants, suggesting 
that CAM-1 might function to regulate the spatial distribution of Wnt/EGL-20 (Table 2A) 
[44]. The hypothesis that CAM-1 can sequester Wnt proteins was recently confirmed by a 
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study of cam-1 function in C. elegans vulva development. During vulva development, cam-1 
mutations result in elevated Wnt pathway activity in the vulval precursor cells (VPCs), and 
overexpression of cam-1 between the source of Wnt expression and the VPCs acts as a 
barrier to reduce Wnt pathway activity in the VPCs [45]. Also, this study showed that the 
membrane-anchored CAM-1 CRD is sufficient to bind Wnt ligands in vitro and non-
autonomously inhibit their activity in vivo.
The function of Ror proteins in other systems is also consistent with Wnt sequestration. For 
example, in U2OS human osteosarcoma cells, Ror2 binds to Wnt1 and Wnt3 and 
antagonizes Wnt1- and Wnt3-mediated stabilization of cytosolic β-catenin by a mechanism 
that does not require the Ror2 kinase domain [46]. However, there are also many examples 
where the influence of Ror proteins on Wnt signaling cannot be explained by simple 
sequestration of Wnt proteins, indicating that Ror functions include additional mechanisms, 
as explained below.
Wnt5a, Ror2 and JNK act in a distinct pathway
Studies of Xenopus convergent extension (CE), a polarized morphogenetic movement in 
which lengthening and narrowing of a field of cells occurs in embryogenesis, showed that 
XRor2 binds to Wnt5a [13] and transmits a Wnt5a signal via the Ser/Thr kinase JNK (c-Jun 
N-terminal kinase) [47]. XWnt5a and XRor2 regulate constriction by activating a JNK 
pathway, which upregulates expression of the paraxial protocadherin XPAPC (Table 2B). 
XPAPC loss-of-function causes constriction defects in Keller explants, which are sections of 
dorsal mesoderm and ectoderm from Xenopus embryos that undergo CE in culture. 
Knockdown of XWnt5a, XRor2 or XJNK phenocopies the constriction defect caused by 
XPAPC loss-of-function. Conversely, XWnt5a overexpression upregulates XPAPC 
expression and this activity requires the kinase domain of XRor2. Activated XJNK similarly 
upregulates XPAPC expression and XJNK activity is stimulated by XWnt5a overexpression 
and is reduced by XWnt5a depletion. Therefore, Wnt5a, Ror2 and JNK probably constitute a 
distinct functional pathway in vivo.
Additional evidence linking Ror2 and Wnt5a comes from mice, where the mWnt5a 
expression pattern is highly similar to that of mRor2 in the developing embryo. The gross 
morphological phenotypes of mRor2 and mWnt5a mutants are also similar; both display 
dwarfism, facial abnormalities and shortened limbs [30, 48, 49]. Subsequent analysis 
revealed a functional relationship between the two gene products. mRor2 physically 
interacts with Wnt5a, but not Wnt3a, in vitro and mRor2 and Wnt5a synergistically activate 
JNK in NIH3T3 cells, supporting the existence of a distinct Wnt5a–Ror2–JNK pathway 
(Table 2B) [49].
Ror and planar cell polarity
PCP is a process wherein cells, or groups of cells, are polarized along the plane of the 
epithelium, perpendicular to the apical–basal axis (reviewed by [50]). PCP is regulated by 
the PCP pathway, which includes the conserved core components Fzd, Dishevelled (Dvl), 
Van Gogh, Prickle and Flamingo. Although the PCP pathway is considered an alternative 
type of Wnt signaling, the contribution of Wnt proteins to PCP is not well understood. Ror2 
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was previously suspected to act in the PCP pathway during Xenopus CE; however, recent 
evidence suggests that XRor2 function during this process occurs by a different mechanism, 
the Wnt5a–Ror2–JNK pathway (see above and Table 2B) [47]. Nevertheless, new studies in 
vertebrates and C. elegans reveal a connection between Ror proteins and PCP signaling after 
all, as described below.
An established model for the study of PCP in vertebrates is the organ of Corti in the 
mammalian inner ear, in which PCP defects manifest as misoriented sensory hair cells. 
mRor2 is strongly expressed in the organ of Corti during embryogenesis and the hair cells of 
mRor2 mutant mice display characteristic PCP abnormalities [51].
CAM-1 regulates the polarity of the C. elegans VPCs [52]. The VPCs are epithelial cells 
that divide asymmetrically along the anterior–posterior axis of the nematode. VPC 
orientation resembles PCP in that the cells are polarized along the plane of the vulval 
epithelium. Several Wnt proteins, including Wnt/EGL-20, determine the orientation of VPC 
division. During VPC orientation, CAM-1 mediates EGL-20 activity by a JNK-independent 
mechanism that requires the CAM-1 intracellular domain (Table 2C). In this process, 
CAM-1 imparts directional information from EGL-20 to the VPCs. Van Gogh, a core 
component of the PCP pathway acts in the same pathway as CAM-1 and EGL-20, 
suggesting that Ror proteins interact with the PCP pathway. It is important to distinguish the 
function of CAM-1 in VPC orientation, which requires the intracellular domain and is thus 
probably cell-autonomous, from the non-autonomous inhibition of Wnt signaling in the 
VPCs when CAM-1 is expressed in other tissues (see above). CAM-1 also regulates 
neuronal polarity and the asymmetric division of several neurons [8]; however, whether 
CAM-1 interacts with Wnt proteins in these processes is unknown.
Ror and cell migration
Another context where the Wnt ligand Wnt5a and Ror2 appear to act together is during cell 
migration. Wnt5a-induced migration of mouse embryonic fibroblasts (MEFs) requires the 
CRD and C-terminal domain of Ror2 (Table 2D) [53]. Treatment of mouse NIH3T3 cells 
with Wnt5a causes glycogen synthase kinase-3 (GSK-3)-mediated phosphorylation of Ror2 
on serine/threonine residues. GSK-3 is required for Wnt5a to mobilize these cells, 
suggesting that phosphorylation of Ror2 by GSK-3 might be required for Ror2 function in 
cell migration [54]. JNK, PKCζ and the actin-binding protein filamin A are also required for 
Wnt5a-induced polarization and cell migration in NIH3T3 cells [55]. Besides the migration 
described above, Ror2 can influence the cytoskeleton independently of Wnt5a, as measured 
by the formation of actin-rich structures known as filopodia. Since these cytoplasmic 
extensions are probably associated with Wnt- and Ror2-mediated cell migration, we will 
discuss them now.
Ror2 overexpression induces filopodia formation in MEFs and this effect is independent of 
the Ror2 CRD and of Wnt5a [53]. Notably, Ror2-induced formation of filopodia is not 
sufficient to stimulate migration; however, it is possible that Ror2 mobilizes the cytoskelton 
allowing MEFs to respond to the Wnt5a migratory cue, when present. In MEF filopodia, 
Ror2 colocalizes with actin and the Ror2 cytoplasmic domain associates with filamin A. The 
C-terminal portion of Ror2 containing the PRD and S/T2 domains is required for association 
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of Ror2 with filamin A. Interestingly, CAM-1, which regulates cell-polarization and cell 
motility in C. elegans, lacks a PRD and has only a single S/T domain (Figure 1). It is 
unknown whether the single S/T domain of CAM-1 can recapitulate the Ror2-filamin A 
interaction.
While Ror2 appears to positively regulate filopodia in MEFs, it has a different effect on 
filopodia in Keller open-face explants, in which knockdown of XRor2 or XWnt5a results in 
an increase in transient filopodia [47]. One explanation that would reconcile these 
observations is that Ror2 functions to stabilize filopodia. In this case, Ror2 overexpression 
might cause increased filopodia, as seen in MEFs, and Ror2 knockdown might cause more 
transient filopodia, as seen in the Keller open-face explants. Ror proteins also influence the 
cytoskeleton in several other cell types. For example, transfection of Ror2 in MCF7 human 
breast cancer cells, T/C28a2 human chondrocytes, mouse B16BL6 melanoma cells, and 
mouse L cells causes extensive formation of filopodia [53, 56]. Also, in cultured 
hippocampal neurons, Ror proteins mobilize the cytoskeleton to regulate neurite and axon 
extension and branching [42].
Ror2 inhibits expression of Wnt target genes
Experiments in cell culture demonstrate that Ror2 modulates the expression of Wnt target 
genes independently of the sequestration mechanism described above for CAM-1. Wnt–β-
catenin pathway activity is commonly measured by a reporter called TOPFLASH that has 
multiple TCF binding sites driving expression of the gene encoding luciferase [57, 58]. 
SUPERTOPFLASH (STF) is similar to TOPFLASH, but has a greater number of TCF sites. 
Ror2 inhibits classic Wnt–β-catenin signaling in mouse L cells and the A549 and H441 
human lung carcinoma cell lines, in which Wnt5a antagonizes Wnt3a-induced STF 
expression in the presence of Ror2 [59] (Table 2E). In human embryonic kidney 293 cells, 
Wnt5a is reported to inhibit Wnt3a-induced STF expression, not by influencing β-catenin 
levels, but by reducing gene expression downstream of β-catenin [60]. This Wnt5a signal is 
mediated by Ror2 and does not involve Ca2+ signaling. Overexpression of Ror2 enhances 
the ability of Wnt5a to block Wnt3a activation of STF and the Ror2 intracellular domain is 
required for this activity, arguing against a sequestration function of Ror2 in this context. 
Contrary to U2OS human osteosarcoma cells where Ror2 binds to Wnt3a, [46], Ror2 does 
not bind to Wnt3a in 293 cells (see specificity section below).
Ror2 promotes expression of Wnt target genes
While the above studies indicate that Ror2 can antagonize Wnt–β-catenin signaling, other 
studies indicate that Ror2 potentiates Wnt–β-catenin signaling in multiple cell types. In 
U2OS osteosarcoma cells, Ror2 potentiates Wnt1-induced TOPFLASH expression by a 
mechanism requiring the Ror2 kinase domain [46]. That Ror2 antagonizes Wnt1-mediated 
stabilization of β-catenin (described above, see sequestration section), yet potentiates the 
transcriptional response to Wnt1 in the same cell line is an enigma and presents a challenge 
to current views of Wnt signaling. One possibility is that the interactions between Ror2 and 
Wnt1 reflect two distinct Ror2 functions. Perhaps Ror2 antagonizes Wnt1-mediated 
stabilization of β-catenin by sequestering Wnt1 (Table 2A) and Ror2 potentiates Wnt1-
induced reporter activation by a signaling mechanism involving the Ror2 kinase domain 
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(Table 2F). In H441 lung carcinoma cells, Ror2 cooperates with the receptor Fzd2 to 
activate STF in response to Wnt3a [59]. In this context, Ror2 function requires the Ror2 
intracellular domain, but not Ror2 kinase activity (Table 2G). Thus, because Ror2 can both 
increase and decrease expression of Wnt reporters, caution should be used when classifying 
Ror proteins as activators or inhibitors of Wnt signaling.
Specificity
Wnt3a binds to Ror2 in U2OS osteosarcoma cells [46], but not in 293 cells [60]. One 
explanation for the difference in binding specificity between the cell types is that 293 cells 
do not express a cofactor necessary for binding. As previously reported [60], a recent study 
similarly showed that Ror2 does not bind to Wnt3a in 293 cells; however, this study showed 
that Ror2 does bind to Wnt3a in 293 cells in the presence of collagen triple helix repeat-
containing protein 1 (Cthrc1), a secreted glycoprotein that stabilizes Wnt ligand–receptor 
interactions [51]. Cthrc1 binds to Wnt proteins and to Ror2 (independently of the Ror2 
CRD), and Cthrc1 enhances binding of both Wnt3a and Wnt5a to Ror2. The Fzd receptor is 
another good candidate for a binding cofactor as Ror2 associates with Wnt3a in 293 cells 
when Fzd6 is co-expressed [51]. Although the Ror2 CRD physically interacts with several 
Fzd receptors, the biological significance of Fzd–Ror interactions has not been tested [49, 
59].
Ror2 homodimerization
Like many other RTKs, Ror proteins form homodimers (Table 2H). Homodimerization of 
Ror2, which occurs upon overexpression in U2OS cells, can be enhanced by treatment with 
a bivalent antibody against Ror2 [61] or by fusion to the dimeric Fc portion of human Ig 
[56]. Ror2 homodimerization results in tyrosine phosphorylation of the receptor [56, 61, 62], 
and, in this regard, Ror2 appears to function as a typical RTK. In U2OS osteosarcoma cells, 
in which both Wnt3a and Wnt5a bind to Ror2 [46], only Wnt5a promotes Ror2 
homodimerization and tyrosine phosphorylation. [62]. In NIH3T3 cells, by contrast, Wnt5a 
does not induce tyrosine phosphorylation of Ror2 (homodimerization was not examined) 
[54]. Again, these differences could be due to the varying cellular contexts.
Downstream of Wnt5a and Ror
Forced dimerization of Ror2 or treatment with Wnt5a activates Ror2 signaling, as evidenced 
by increased bone formation in organ culture and increased osteogenesis in human 
mesenchymal stem cells (hMSCs) [61-63]. These effects could be mediated by inhibition of 
the cytoplasmic14-3-3-β scaffold protein, which antagonizes osteogenesis. 
Immunoprecipitation followed by mass-spectrometric analysis of FLAG-tagged Ror2 
revealed that the 14-3-3-β scaffold protein is a Ror2 binding partner (Table 2H). In U2OS 
osteosarcoma cells, the Ror2 intracellular domain directly interacts with and phosphorylates 
14-3-3-β, and treatment with Wnt5a also promotes phosphorylation of 14-3-3-β. 
Interestingly, 14-3-3-β exhibits stronger binding to kinase-inactive Ror2 (Ror2-KD) than to 
wild-type Ror2, suggesting that 14-3-3-β might be released by Ror2 phosphorylation.
Another candidate signal transducer is Src protein-tyrosine kinase, which is activated when 
Ror2-expressing T/C28a2 human chondrocytes are treated with Wnt5a [56]. In these cells, 
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activation by Wnt5a causes robust tyrosine phosphorylation of Ror2 followed by rapid 
internalization of Ror2. While most functional studies of mammalian Ror proteins have 
focused on Ror2 because of its disease association, Wnt5a also binds to Ror1, and co-
transfection of these two proteins in 293 cells causes activation of the pleiotropic 
transcription factor NF-κB [34]. Thus, NF-κB is another potential downstream effector of 
Wnt5a–Ror signaling.
While the signaling cascade downstream of activated Ror is poorly understood, some of the 
components that interact with the Ror intracellular domain are beginning to be elucidated. 
The interactions below are not apparently related to Wnt signaling, but a connection to Wnt 
signaling might be exposed upon further investigation.
Potentially Wnt-independent Ror functions
A yeast-two-hybrid (Y2H) protein–protein interaction screen using the mRor1 and mRor2 
C-termini as bait identified Dlxin-1 as a protein that interacts with Ror2 but not with Ror1 
(Table 3A) [64]. Dlxin-1 is a melanoma-associated-antigen (MAGE) family member and 
was confirmed to bind to Ror2, but not to Ror1, by co-immunoprecipitation. Ror2 kinase 
activity is not required for this association. Ror2, by means of its C-terminal proline-rich or 
S/T2 domains, recruits Dlxin-1 from the cytoplasm to the plasma membrane, and Dlxin-1 is 
localized to the nucleus in the absence of Ror2. Through this subcellular localization, Ror2 
indirectly affects the transcriptional activity of the Dlxin-1 interactor Msx2. Consistent with 
an interaction between Ror2 and Dlxin-1, their spatiotemporal expression patterns 
significantly overlap in the developing mouse face and lung. As with the interaction of Ror2 
with filamin A during cell migration (see above), it will be interesting to see whether the 
single S/T domain in the CAM-1 C-terminus is sufficient to recapitulate the Ror2–Dlixin-1 
interaction.
This Y2H screen also identified casein kinase I epsilon (CKIε) as a Ror2 binding partner. 
Endogenous Ror2 and CKIε co-immunoprecipitated from NIH3T3 cells and also 
coimmunoprecipitated when overexpressed in 293 cells (Table 3B) [65]. CKIε 
phosphorylates Ser/Thr residues in the S/T2 domain of Ror2 and induces 
autophosphorylation of tyrosine residues in the Ror2 proline-rich domain. After activation 
by CKIε, Ror2 associates with and tyrosine phosphorylates G-protein-coupled receptor 
kinase 2 (GRK2/beta-adrenergic receptor kinase 1). The expression pattern of GRK2 is 
similar to that of Ror2 and Dlxin-1 in mice [65]. Association of Ror2 with CKIε may be 
specific to vertebrates, as invertebrate Ror proteins do not have the proline-rich domain 
(Figure 1). Neither the Ror2-Dlixin-1 nor the Ror2- CKIε interactions have thus far been 
associated with any biological function.
Another study, using a candidate-driven approach, identified growth/differentiation factor 5 
(GDF5) and bone morphogenetic protein receptor type-1B (BMPR1b) as Ror-interacting 
proteins [66]. This study was based on the premise that the molecular mechanisms 
responsible for BDB, caused by Ror2 mutation, might be shared among other forms of 
brachydactyly. Brachdactyly type C (BDC) and brachydactyly type A2 (BDA2) are caused 
by mutation in the gene encoding GDF5, which is a TGF-β/BMP family member, and its 
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receptor, BMPR1b, respectively. A genetic and physical interaction between Ror2, BMPR1b 
and GDF5 was described, in which BMPR1b binds to and phosphorylates Ror2, which 
inhibits the GDF5–BMPR1b pathway (Table 3C). A relationship between Ror2 and BMP 
signaling was reproduced in a second study where mutations were detected in the gene 
encoding the GDF5 antagonist NOGGIN, in patients with BDB without Ror2 mutations 
[67]. The signaling events that take place following these interactions and the mechanism by 
which they cause the brachydactyly phenotype are presently unclear. It remains to be shown 
whether GDF5 directly binds to Ror2 and if so, which domains are involved.
Remaining questions and future directions
Ror proteins are involved in a multitude of cellular processes and signaling events. A 
striking theme, however, is that Ror proteins function as Wnt receptors. In particular, there 
is general consensus that Wnt5a binds to and activates Ror2; therefore, Wnt5a can be 
considered a bona fide Ror2 ligand. While much progress has been made in understanding 
Ror2 function as a Wnt receptor, several key questions remain unanswered. What is the 
connection between Ror and the PCP pathway? What is the mechanism by which Ror2 
either activates or inhibits Wnt targets? What determines whether Ror2 will transduce a Wnt 
signal versus sequester the Wnt? Are these exclusive functions or do both occur at once? 
Future work should address these issues.
While there is abundant evidence in many systems that Ror proteins act as Wnt receptors, 
most of these functions depend on the CRD. To date, there is no knowledge of the function 
of the other extracellular domains – Kringle and Ig. These domains could be required to 
interact with a co-receptor, or be involved in receptor localization, or they could be required 
for binding to unidentified non-Wnt ligands. Similarly, the function of the intracellular 
domain remains ambiguous. Studies involving Y2H assays and mass-spectrometry, as well 
as candidate-driven approaches, have identified multiple potential binding partners; however 
the biological significance of many of these interactions remains to be determined.
Ror2 has been the focus of many studies because of its involvement in human disease; by 
contrast, Ror1 function has been studied less rigorously. In light of its recent implication in 
human cancer, it will be important also to decipher the signaling properties of Ror1. The 
unique domain architecture of these RTKs and the variety of processes in which they are 
involved hold promise for exciting revelations about Ror signaling. While great progress has 
been made in placing these orphan receptors into the cellular signaling network, Ror 
signaling remains rich with mystery.
Acknowledgements
P.W.S. is an investigator with the HHMI. J.L.G. was supported by the Thomas Hunt Morgan Fellowship and 
S.G.K. was supported by the NIH training grant for graduate study toward the Doctor of Philosophy degree in 
Biology at the California Institute of Technology.
References
1. Matsuda T, et al. Expression of the receptor tyrosine kinase genes, Ror1 and Ror2, during mouse 
development. Mech Dev. 2001; 105(1-2):153–6. [PubMed: 11429290] 
Green et al. Page 9
Trends Cell Biol. Author manuscript; available in PMC 2015 December 08.
H
H
M
I Author M
anuscript
H
H
M
I Author M
anuscript
H
H
M
I Author M
anuscript
2. Masiakowski P, Carroll RD. A novel family of cell surface receptors with tyrosine kinase-like 
domain. J Biol Chem. 1992; 267(36):26181–90. [PubMed: 1334494] 
3. Reddy UR, Phatak S, Pleasure D. Human neural tissues express a truncated Ror1 receptor tyrosine 
kinase, lacking both extracellular and transmembrane domains. Oncogene. 1996; 13(7):1555–9. 
[PubMed: 8875995] 
4. Al-Shawi R, et al. Expression of the Ror1 and Ror2 receptor tyrosine kinase genes during mouse 
development. Dev Genes Evol. 2001; 211(4):161–71. [PubMed: 11455430] 
5. Oishi I, et al. Spatio-temporally regulated expression of receptor tyrosine kinases, mRor1, mRor2, 
during mouse development: implications in development and function of the nervous system. Genes 
Cells. 1999; 4(1):41–56. [PubMed: 10231392] 
6. Wilson C, Goberdhan DC, Steller H. Dror, a potential neurotrophic receptor gene, encodes a 
Drosophila homolog of the vertebrate Ror family of Trk-related receptor tyrosine kinases. Proc Natl 
Acad Sci U S A. 1993; 90(15):7109–13. [PubMed: 8394009] 
7. Koga M, et al. Control of DAF-7 TGF-(alpha) expression and neuronal process development by a 
receptor tyrosine kinase KIN-8 in Caenorhabditis elegans. Development. 1999; 126(23):5387–98. 
[PubMed: 10556063] 
8. Forrester WC, et al. A C. elegans Ror receptor tyrosine kinase regulates cell motility and 
asymmetric cell division. Nature. 1999; 400(6747):881–5. [PubMed: 10476968] 
9. McKay SE, et al. Aplysia ror forms clusters on the surface of identified neuroendocrine cells. Mol 
Cell Neurosci. 2001; 17(5):821–41. [PubMed: 11358481] 
10. Katoh M, Katoh M. Comparative genomics on ROR1 and ROR2 orthologs. Oncol Rep. 2005; 
14(5):1381–4. [PubMed: 16211313] 
11. Rodriguez-Niedenfuhr M, Prols F, Christ B. Expression and regulation of ROR-1 during early 
avian limb development. Anat Embryol (Berl). 2004; 207(6):495–502. [PubMed: 14758549] 
12. Stricker S, et al. Cloning and expression pattern of chicken Ror2 and functional characterization of 
truncating mutations in Brachydactyly type B and Robinow syndrome. Dev Dyn. 2006; 235(12):
3456–65. [PubMed: 17061261] 
13. Hikasa H, et al. The Xenopus receptor tyrosine kinase Xror2 modulates morphogenetic movements 
of the axial mesoderm and neuroectoderm via Wnt signaling. Development. 2002; 129(22):5227–
39. [PubMed: 12399314] 
14. Oishi I, et al. A novel Drosophila receptor tyrosine kinase expressed specifically in the nervous 
system. Unique structural features and implication in developmental signaling. J Biol Chem. 1997; 
272(18):11916–23. [PubMed: 9115253] 
15. Sossin WS. Tracing the evolution and function of the Trk superfamily of receptor tyrosine kinases. 
Brain Behav Evol. 2006; 68(3):145–56. [PubMed: 16912468] 
16. Saldanha J, Singh J, Mahadevan D. Identification of a Frizzled-like cysteine rich domain in the 
extracellular region of developmental receptor tyrosine kinases. Protein Sci. 1998; 7(8):1632–5.
17. Roszmusz E, et al. Localization of disulfide bonds in the frizzled module of Ror1 receptor tyrosine 
kinase. J Biol Chem. 2001; 276(21):18485–90. [PubMed: 11279007] 
18. Xu YK, Nusse R. The Frizzled CRD domain is conserved in diverse proteins including several 
receptor tyrosine kinases. Curr Biol. 1998; 8(12):R405–6. [PubMed: 9637908] 
19. Masiakowski P, Yancopoulos GD. The Wnt receptor CRD domain is also found in MuSK and 
related orphan receptor tyrosine kinases. Curr Biol. 1998; 8(12):R407. [PubMed: 9637909] 
20. Rehn M, et al. The frizzled motif: in how many different protein families does it occur? Trends 
Biochem Sci. 1998; 23(11):415–7. [PubMed: 9852758] 
21. Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev 
Biol. 2004; 20:781–810. [PubMed: 15473860] 
22. Veeman MT, Axelrod JD, Moon RT. A second canon. Functions and mechanisms of beta-catenin-
independent Wnt signaling. Dev Cell. 2003; 5(3):367–77. [PubMed: 12967557] 
23. Oldridge M, et al. Dominant mutations in ROR2, encoding an orphan receptor tyrosine kinase, 
cause brachydactyly type B. Nat Genet. 2000; 24(3):275–8. [PubMed: 10700182] 
24. Schwabe GC, et al. Distinct mutations in the receptor tyrosine kinase gene ROR2 cause 
brachydactyly type B. Am J Hum Genet. 2000; 67(4):822–31. [PubMed: 10986040] 
Green et al. Page 10
Trends Cell Biol. Author manuscript; available in PMC 2015 December 08.
H
H
M
I Author M
anuscript
H
H
M
I Author M
anuscript
H
H
M
I Author M
anuscript
25. van Bokhoven H, et al. Mutation of the gene encoding the ROR2 tyrosine kinase causes autosomal 
recessive Robinow syndrome. Nat Genet. 2000; 25(4):423–6. [PubMed: 10932187] 
26. Afzal AR, et al. Recessive Robinow syndrome, allelic to dominant brachydactyly type B, is caused 
by mutation of ROR2. Nat Genet. 2000; 25(4):419–22. [PubMed: 10932186] 
27. Ermakov S, et al. Family-based association study of ROR2 polymorphisms with an array of 
radiographic hand bone strength phenotypes. Osteoporos Int. 2007
28. Nomi M, et al. Loss of mRor1 enhances the heart and skeletal abnormalities in mRor2-deficient 
mice: redundant and pleiotropic functions of mRor1 and mRor2 receptor tyrosine kinases. Mol 
Cell Biol. 2001; 21(24):8329–35. [PubMed: 11713269] 
29. DeChiara TM, et al. Ror2, encoding a receptor-like tyrosine kinase, is required for cartilage and 
growth plate development. Nat Genet. 2000; 24(3):271–4. [PubMed: 10700181] 
30. Takeuchi S, et al. Mouse Ror2 receptor tyrosine kinase is required for the heart development and 
limb formation. Genes Cells. 2000; 5(1):71–8. [PubMed: 10651906] 
31. Schwabe GC, et al. Ror2 knockout mouse as a model for the developmental pathology of 
autosomal recessive Robinow syndrome. Dev Dyn. 2004; 229(2):400–10. [PubMed: 14745966] 
32. Raz R, et al. The mutation ROR2W749X, linked to human BDB, is a recessive mutation in the 
mouse, causing brachydactyly, mediating patterning of joints and modeling recessive Robinow 
syndrome. Development. 2008
33. Baskar S, et al. Unique Cell Surface Expression of Receptor Tyrosine Kinase ROR1 in Human B-
Cell Chronic Lymphocytic Leukemia. Clin Cancer Res. 2008; 14(2):396–404. [PubMed: 
18223214] 
34. Fukuda T, et al. Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify 
ROR1 as an oncofetal antigen and receptor for Wnt5a. Proc Natl Acad Sci U S A. 2008
35. MacKeigan JP, Murphy LO, Blenis J. Sensitized RNAi screen of human kinases and phosphatases 
identifies new regulators of apoptosis and chemoresistance. Nat Cell Biol. 2005; 7(6):591–600. 
[PubMed: 15864305] 
36. DeChiara TM, et al. The receptor tyrosine kinase MuSK is required for neuromuscular junction 
formation in vivo. Cell. 1996; 85(4):501–12. [PubMed: 8653786] 
37. Zinovyeva AY, et al. Complex Network of Wnt Signaling Regulates Neuronal Migrations During 
Caenorhabditis elegans Development. Genetics. 2008; 179(3):1357–71. [PubMed: 18622031] 
38. Forrester WC, Garriga G. Genes necessary for C. elegans cell and growth cone migrations. 
Development. 1997; 124(9):1831–43. [PubMed: 9165130] 
39. Forrester WC, Kim C, Garriga G. The Caenorhabditis elegans Ror RTK CAM-1 inhibits 
EGL-20/Wnt signaling in cell migration. Genetics. 2004; 168(4):1951–62. [PubMed: 15371357] 
40. Francis MM, et al. The Ror receptor tyrosine kinase CAM-1 is required for ACR-16- mediated 
synaptic transmission at the C. elegans neuromuscular junction. Neuron. 2005; 46(4):581–94. 
[PubMed: 15944127] 
41. Paganoni S, Ferreira A. Expression and subcellular localization of Ror tyrosine kinase receptors 
are developmentally regulated in cultured hippocampal neurons. J Neurosci Res. 2003; 73(4):429–
40. [PubMed: 12898527] 
42. Paganoni S, Ferreira A. Neurite extension in central neurons: a novel role for the receptor tyrosine 
kinases Ror1 and Ror2. J Cell Sci. 2005; 118(Pt 2):433–46. [PubMed: 15654020] 
43. Paganoni S, Anderson KL, Ferreira A. Differential subcellular localization of Ror tyrosine kinase 
receptors in cultured astrocytes. Glia. 2004; 46(4):456–66. [PubMed: 15095375] 
44. Kim C, Forrester WC. Functional analysis of the domains of the C elegans Ror receptor tyrosine 
kinase CAM-1. Dev Biol. 2003; 264(2):376–90. [PubMed: 14651925] 
45. Green JL, Inoue T, Sternberg PW. The C. elegans ROR receptor tyrosine kinase, CAM-1, non-
autonomously inhibits the Wnt pathway. Development. 2007; 134(22):4053–62. [PubMed: 
17942487] 
46. Billiard J, et al. The orphan receptor tyrosine kinase Ror2 modulates canonical Wnt signaling in 
osteoblastic cells. Mol Endocrinol. 2005; 19(1):90–101. [PubMed: 15388793] 
47. Schambony A, Wedlich D. Wnt-5A/Ror2 regulate expression of XPAPC through an alternative 
noncanonical signaling pathway. Dev Cell. 2007; 12(5):779–92. [PubMed: 17488628] 
Green et al. Page 11
Trends Cell Biol. Author manuscript; available in PMC 2015 December 08.
H
H
M
I Author M
anuscript
H
H
M
I Author M
anuscript
H
H
M
I Author M
anuscript
48. Yamaguchi TP, et al. A Wnt5a pathway underlies outgrowth of multiple structures in the vertebrate 
embryo. Development. 1999; 126(6):1211–23. [PubMed: 10021340] 
49. Oishi I, et al. The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5a/JNK 
signalling pathway. Genes Cells. 2003; 8(7):645–54. [PubMed: 12839624] 
50. Seifert JR, Mlodzik M. Frizzled/PCP signalling: a conserved mechanism regulating cell polarity 
and directed motility. Nat Rev Genet. 2007; 8(2):126–38. [PubMed: 17230199] 
51. Yamamoto S, et al. Cthrc1 selectively activates the planar cell polarity pathway of Wnt signaling 
by stabilizing the Wnt-receptor complex. Dev Cell. 2008; 15(1):23–36. [PubMed: 18606138] 
52. Green JL, Inoue T, Sternberg PW. Opposing Wnt pathways orient cell polarity during 
organogenesis. Cell. 2008 In press. 
53. Nishita M, et al. Filopodia formation mediated by receptor tyrosine kinase Ror2 is required for 
Wnt5a-induced cell migration. J Cell Biol. 2006; 175(4):555–62. [PubMed: 17101698] 
54. Yamamoto H, et al. Wnt5a modulates glycogen synthase kinase 3 to induce phosphorylation of 
receptor tyrosine kinase Ror2. Genes Cells. 2007; 12(11):1215–23. [PubMed: 17986005] 
55. Nomachi A, et al. Receptor tyrosine kinase Ror2 mediates Wnt5a-induced polarized cell migration 
by activating c-Jun N-terminal kinase via actin-binding protein filamin A. J Biol Chem. 2008
56. Akbarzadeh S, et al. The deleted in brachydactyly B domain of ROR2 is required for receptor 
activation by recruitment of Src. PLoS ONE. 2008; 3(3):e1873. [PubMed: 18365018] 
57. Molenaar M, et al. XTcf-3 transcription factor mediates beta-catenin-induced axis formation in 
Xenopus embryos. Cell. 1996; 86(3):391–9. [PubMed: 8756721] 
58. van de Wetering M, et al. Armadillo coactivates transcription driven by the product of the 
Drosophila segment polarity gene dTCF. Cell. 1997; 88(6):789–99. [PubMed: 9118222] 
59. Li C, et al. Ror2 modulates the canonical Wnt signaling in lung epithelial cells through cooperation 
with Fzd2. BMC Mol Biol. 2008; 9:11. [PubMed: 18215320] 
60. Mikels AJ, Nusse R. Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling 
depending on receptor context. PLoS Biol. 2006; 4(4):e115. [PubMed: 16602827] 
61. Liu Y, et al. Homo-dimerization of Ror2 Tyrosine Kinase Receptor Induces 14 3-3{beta} 
Phosphorylation and Promotes Osteoblast Differentiation and Bone Formation. Mol Endocrinol. 
2007
62. Liu Y, et al. Wnt5a induces homodimerization and activation of Ror2 receptor tyrosine kinase. J 
Cell Biochem. 2008
63. Liu Y, et al. The orphan receptor tyrosine kinase Ror2 promotes osteoblast differentiation and 
enhances ex vivo bone formation. Mol Endocrinol. 2007; 21(2):376–87. [PubMed: 17095577] 
64. Matsuda T, et al. The receptor tyrosine kinase Ror2 associates with the melanoma-associated 
antigen (MAGE) family protein Dlxin-1 and regulates its intracellular distribution. J Biol Chem. 
2003; 278(31):29057–64. [PubMed: 12754255] 
65. Kani S, et al. The receptor tyrosine kinase Ror2 associates with and is activated by casein kinase 
Iepsilon. J Biol Chem. 2004; 279(48):50102–9. [PubMed: 15375164] 
66. Sammar M, et al. Modulation of GDF5/BRI-b signalling through interaction with the tyrosine 
kinase receptor Ror2. Genes Cells. 2004; 9(12):1227–38. [PubMed: 15569154] 
67. Lehmann K, et al. A new subtype of brachydactyly type B caused by point mutations in the bone 
morphogenetic protein antagonist NOGGIN. Am J Hum Genet. 2007; 81(2):388–96. [PubMed: 
17668388] 
68. Hubbard SR, Till JH. Protein tyrosine kinase structure and function. Annu Rev Biochem. 2000; 
69:373–98. [PubMed: 10966463] 
69. Forrester WC. The Ror receptor tyrosine kinase family. Cell Mol Life Sci. 2002; 59(1):83–96. 
[PubMed: 11846036] 
70. Zhang H, et al. Heterodimerization of Msx and Dlx homeoproteins results in functional 
antagonism. Mol Cell Biol. 1997; 17(5):2920–32. [PubMed: 9111364] 
71. Thompson JD, et al. The CLUSTAL_X windows interface: flexible strategies for multiple 
sequence alignment aided by quality analysis tools. Nucleic Acids Res. 1997; 25(24):4876–82. 
[PubMed: 9396791] 
Green et al. Page 12
Trends Cell Biol. Author manuscript; available in PMC 2015 December 08.
H
H
M
I Author M
anuscript
H
H
M
I Author M
anuscript
H
H
M
I Author M
anuscript
Box 1. Evolution of Ror
The Ror family is part of the NTRK superfamily of receptor tyrosine kinases, which also 
includes the MuSK (muscle-specific kinase) and Nrk (neuro-specific receptor kinase) 
family, the Ddr (Discoidin domain receptors) family, and the Ntrk (neurotrophic tyrosine 
kinase) family, also known as the Trk (tropomyosin-related kinase) family (Box Figure 
1). The Ddr family appears to have split from the ancestral family first, being present as a 
separate family in the sponges (Porifera). The sponge Frizzled-Kringle protein might be 
representative of an ancestral family of proteins present in early metazoa, before the Ror, 
MuSK, and Ntrk split. The Ntrk proteins appear to have branched off near the same time 
as the MuSK and Ror split, although Ror and Ddr are the only families present in sea 
anemone (Cnidaria) and demonstrably basal to bilateria [15]. All four families must have 
been present in early bilateria, though different families have been lost in divergent 
modern phyla. While vertebrates retain all four families, molluscs appear to have lost the 
Ddr family, insects have lost the Ntrk family (Dnrk is now viewed as a representative of 
the MuSK and Nrk family owing to domain and sequence similarity), and nematodes 
have lost both the Ntrk and the MuSK families [15]. Certain species have significantly 
more divergent representatives of a family than would be expected for their phyla (such 
as the echinoderm Ror proteins that appear basal to those of vertebrates, molluscs and 
arthropods), indicating rapid evolution of various domains, especially the kinase domain. 
C. elegans CAM-1, whose conserved kinase, kringle and Ig domains clearly place it in 
the Ror family, has a cysteine-rich (Frizzled) domain, whose amino acid sequence 
resembles that of a MuSK as much as that of a Ror [8, 15]. As nematodes lack MuSK, 
the cam-1 frizzled domain could be converging with the MuSK frizzled domains of other 
organisms. The propensity for continued duplication and mutation of this family is 
reflected in the more recent divergence of Ror1 and Ror2 and Ddr1 and Ddr2 in early 
vertebrates.
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Figure 1. Structure of Ror RTKs in different species
Structure of Ror receptor tyrosine kinases (RTKs) in different species. Domain organization 
(approximately to scale) of Ror proteins in human (hROR1, hROR2), mouse (mRor1, 
mRor2), C. elegans (CAM-1) and Drosophila (dROR). The N-terminal extracellular domain 
(ECD) is above and the intracellular domain (ICD) is below the double line representing the 
plasma membrane (image adapted from Refs [68, 69]).
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Figure 2. 
Ror proteins as Wnt receptors
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Figure 3. 
Other Ror functions
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Box Figure 1. The different families within the NTRK superfamily of tyrosine kinases
The tree, which has no root, represents an approximation of the evolutionary divergence, as 
different domains within the proteins have evolved at different rates in different species and 
have experienced independent introductions of the Ig domain. Highlighted are the NTRK 
(blue), Ddr (green), MuSK/Nrk (red), and Ror (yellow) families; each line represents a 
single protein from a species in the labelled clade (i.e. the three lines for nematode CAM-1 
represent CAM-1 of C. elegans, Brugia malayi, and Pristionchus pacificus). The sponge 
Frizzled-Kringle protein (black) does not fit into any family. Sequences are from GenBank 
(http://www.ncbi.nlm.nih.gov/sites/entrez), Ensembl (http://www.ensembl.org), UCSC 
Genome Browser (http://genome.ucsc.edu), and JGI (http://genome.jgi-psf.org). Tree 
generated by ClustalX (v1.83.1; [71]) and Phylodendron (v0.8d; http://iubio.bio.indiana.edu/
treeapp/treeprint-form.html).
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